James Rickard
Overview
Explore the profile of James Rickard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olszewska A, Duan J, Javorovic J, Chan K, Rickard J, Pitchford S, et al.
Gels
. 2024 Sep;
10(9).
PMID: 39330174
This observational study reports the process for the manufacture of RAPID Biodynamic Haematogel and explores the properties of the platelet and leukocyte-rich plasma gels formed. Gels were manufactured from 60...
2.
Jain R, Zhao K, Sheridan J, Heinlein M, Kupresanin F, Abeysekera W, et al.
Cell Death Differ
. 2021 Aug;
28(10):2946-2956.
PMID: 34381167
Thymic epithelial cells (TECs) form a unique microenvironment that orchestrates T cell differentiation and immunological tolerance. Despite the importance of TECs for adaptive immunity, there is an incomplete understanding of...
3.
Sessa B, Higbed L, OBrien S, Durant C, Sakal C, Titheradge D, et al.
J Psychopharmacol
. 2021 Feb;
35(4):375-383.
PMID: 33601929
Background: 3,4-methylenedioxymethamphetamine (MDMA) therapy has qualities that make it potentially well suited for patients with addictions, but this has never been explored in a research study. We present data from...
4.
Sasadeusz J, Grigg A, Hughes P, Lim S, Lucas M, McColl G, et al.
Clin Liver Dis
. 2019 Jul;
23(3):521-534.
PMID: 31266625
Because of the relatively high prevalence of both hepatitis B infection and various forms of autoimmune inflammatory diseases treated with aggressive immunotherapy, reactivation of hepatitis B occurs in a substantial...
5.
Sasadeusz J, Grigg A, Hughes P, Lim S, Lucas M, McColl G, et al.
Clin Liver Dis
. 2019 Jul;
23(3):511-519.
PMID: 31266624
Patients with malignancies require chemotherapy and other immunosuppressive therapies for treatment. Because of this immunosuppression, in patients who have ever been exposed to hepatitis B it is possible for reactivation...
6.
Sasadeusz J, Grigg A, Hughes P, Lim S, Lucas M, McColl G, et al.
Clin Liver Dis
. 2019 Jul;
23(3):493-509.
PMID: 31266623
Organ transplantation is a lifesaving procedure for many patients. To prevent rejection or graft-versus-host disease, recipients require long-term immunosuppression. In patients who have ever been exposed to hepatitis B, it...
7.
Sasadeusz J, Grigg A, Hughes P, Lim S, Lucas M, McColl G, et al.
Clin Liver Dis
. 2019 Jul;
23(3):487-492.
PMID: 31266622
Current recommendations concerning hepatitis C virus (HBV) reactivation are limited, with nearly all guidelines focused on its occurrence in patients with hematological malignancies or some solid tumors, who are treated...
8.
Peltzer N, Darding M, Montinaro A, Draber P, Draberova H, Kupka S, et al.
Nature
. 2018 Apr;
557(7703):112-117.
PMID: 29695863
The linear ubiquitin chain assembly complex (LUBAC) is required for optimal gene activation and prevention of cell death upon activation of immune receptors, including TNFR1 . Deficiency in the LUBAC...
9.
Gentle I, Wong W, Evans J, Bankovacki A, Cook W, Khan N, et al.
J Biol Chem
. 2016 Jan;
291(5):2547.
PMID: 26826208
No abstract available.
10.
Gentle I, Wong W, Evans J, Bankovacki A, Cook W, Khan N, et al.
J Biol Chem
. 2011 Feb;
286(15):13282-91.
PMID: 21339290
RIPK1 is involved in signaling from TNF and TLR family receptors. After receptor ligation, RIPK1 not only modulates activation of both canonical and NIK-dependent NF-κB, but also regulates caspase-8 activation...